ストックスクリーナーアプリを入手
96.91
1.72%
1.64
アフターアワーズ：
97.40
0.49
+0.51%
Incyte Corp (INCY) 最新ニュース
Sanctuary Advisors LLC Has $3.16 Million Holdings in Incyte Corporation $INCY - MarketBeat
Incyte (INCY) Gains FDA Approval for Jakafi XR Treatment - GuruFocus
FDA approves Incyte’s once-daily Jakafi XR formulation - Investing.com
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease - ChartMill
Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch
Incyte: Strong Business, But Risks Remain (NASDAQ:INCY) - Seeking Alpha
Earnings Beat: Incyte Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
INCY Q1 earnings and revenues beat estimates on higher product sales - MSN
INCY SWOT Analysis: Strong Financial Performance Revealed in 10-Q Filing - GuruFocus
Incyte Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Vanguard Capital Management (INCY) discloses 6.32% ownership in Incyte Corp - Stock Titan
GC Wealth Management RIA LLC Takes Position in Incyte Corporation $INCY - MarketBeat
Vanguard Group Inc. Sells 40,189 Shares of Incyte Corporation $INCY - MarketBeat
Incyte gears up to report Q1 earnings: What can investors expect? - MSN
INCY Maintained by Oppenheimer -- Price Target Raised to $90 - GuruFocus
Stifel raises Incyte stock price target to $123 on earnings beat By Investing.com - Investing.com India
Stifel raises Incyte stock price target to $123 on earnings beat - Investing.com Australia
Incyte to Present at Upcoming May 2026 Investor Conferences - BioSpace
Q4 2025 Incyte Corp Earnings Call Transcript - GuruFocus
INCY Maintained by Stifel -- Price Target Raised to $123 - GuruFocus
Stifel Nicolaus Increases Incyte (NASDAQ:INCY) Price Target to $123.00 - MarketBeat
H.C. Wainwright reiterates Incyte stock rating on Jakafi outlook - Investing.com
Incyte Corporation (NASDAQ:INCY) Q1 2026 Earnings Call Transcript - Insider Monkey
Incyte to Present at Upcoming Investor Conferences - Yahoo Finance
Incyte Corp (INCY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Promising Pipeline Developments - GuruFocus
INCY Financials: Income Statement, Balance Sheet & Cash Flow | Incyte Corp - Stock Titan
Morgan Stanley raises Incyte stock price target on solid results By Investing.com - Investing.com Nigeria
Oppenheimer raises Incyte stock price target on earnings beat By Investing.com - Investing.com South Africa
Oppenheimer raises Incyte stock price target on earnings beat - Investing.com
Morgan Stanley raises Incyte stock price target on solid results - Investing.com UK
Incyte Welcomes Suky Upadhyay as EVP, CFO - Contract Pharma
[ARS] INCYTE CORP SEC Filing - Stock Titan
Incyte (NASDAQ: INCY) posts 2025 growth, outlines pipeline and pay plan - Stock Titan
Robust Q1 2026 growth at Incyte (NASDAQ: INCY) driven by key drug sales - Stock Titan
TD Cowen raises Incyte stock price target to $124 on demand outlook - Investing.com
Incyte (INCY) Reports Strong Q1 2026 Sales Growth and Strategic Developments - GuruFocus
Incyte (INCY) Q1 2026 Earnings Call Transcript - The Globe and Mail
Incyte (INCY) Q2 2025 Earnings Transcript - The Globe and Mail
Incyte Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Incyte (INCY) Exceeds Q1 2026 Earnings Expectations with Strong Drug Demand - GuruFocus
Incyte Appoints Suketu (Suky) Upadhyay as Chief Financial Officer - BioSpace
Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates - BioSpace
INCY Q1 Earnings and Revenues Beat Estimates on Higher Product Sales - Yahoo Finance
Incyte (NASDAQ:INCY) Announces Earnings Results, Beats Expectations By $0.47 EPS - MarketBeat
Incyte Q1 Earnings Call Highlights - MarketBeat
Incyte Q1 2026 slides: 21% revenue growth, portfolio diversification accelerates - Investing.com
Earnings call transcript: Incyte Q1 2026 beats earnings expectations - Investing.com
Compared to Estimates, Incyte (INCY) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Incyte (INCY) Reports Strong Q1 Earnings with Significant Revenue Growth - GuruFocus
Incyte (INCY) Posts Strong Q1 Revenue and Plans for New Product Launches - GuruFocus
Incyte's strong Q1 beat contrasts with QIAGEN outlook cut - MSN
Incyte (NASDAQ:INCY) Beats Q1 Estimates and Unveils Robust Pipeline Catalysts - ChartMill
Incyte (INCY) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Q1 2026 Incyte Corp Earnings Call Transcript - GuruFocus
Is Incyte (INCY) 3.3% Undervalued After Q1 2026 Earnings Beat? E - GuruFocus
Incyte stock falls nearly 4% despite beating first quarter estimates By Investing.com - Investing.com South Africa
Incyte names Suketu Upadhyay as CFO effective May 4 - Investing.com
Incyte (NASDAQ:INCY) Exceeds Q1 CY2026 Expectations - Barchart.com
Incyte: Q1 Earnings Snapshot - kare11.com
Incyte lines up 4 drug launches after $1.27B revenue quarter - Stock Titan
2.45%
大文字化:
|
ボリューム (24 時間):